111 (YI) FCF Margin (2017 - 2025)

111 (YI) posted FCF Margin of 1.06% for Q4 2025, down 16.57% sequentially from 1.27% in Q3 2025, and up 232.0% YoY from 0.32% in Q4 2024.

111 (YI) FCF Margin (2017 - 2025) Analysis & Trends

111 has reported FCF Margin for 9 years, with the latest figure at 1.06% in Q4 2025.

Quarterly FCF Margin rose 232.0% year-over-year to 1.06% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.95% (down 90.0% YoY) and the FY2025 annual result came in at 0.92%, down 90.0% from the prior year.
FCF Margin retreated to 1.06% in Q4 2025 per YI's latest filing, from 1.27% in the prior quarter.
Over five years, FCF Margin peaked at 3.18% in Q1 2025 and troughed at 10.0% in Q1 2021.
A 5-year average of 1.16% and a median of 0.63% in 2021 frame the typical range for FCF Margin.
The sharpest annual moves came in 2021 and 2022: FCF Margin sank 804 bps in 2021, then jumped 927 bps in 2022.
Over 5 years, FCF Margin stood at 7.75% in 2021, then surged by 120 bps to 1.52% in 2022, then plunged by 415 bps to 4.8% in 2023, then soared by 74 bps to 1.26% in 2024, then surged by 184 bps to 1.06% in 2025.
According to Business Quant data, FCF Margin over the past three periods registered 1.06%, 1.27%, and 1.9% for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Mckesson	100.02 Bn	94.85 Bn	3.69 Bn	-0.32%
2	Cencora	60.88 Bn	58.06 Bn	3.61 Bn	2.86%
3	Cardinal Health	54.14 Bn	49.29 Bn	2.56 Bn	2.24%
4	Henry Schein	10.05 Bn	9.90 Bn	1.10 Bn	6.13%
5	Akso Health	737.16 Mn	736.96 Mn	-	-
6	Edap Tms	159.12 Mn	137.58 Mn	7.34 Mn	-29.43%
7	Accendra Health	100.85 Mn	93.20 Mn	263.41 Mn	-7.05%
8	111	32.10 Mn	-26.65 Mn	18.18 Mn	-3.87%
9	Cosmos Health	12.73 Mn	10.29 Mn	1.51 Mn	-9.39%
10	VitaNova Life Sciences	11.51 Mn	9.91 Mn	264,662.00	24.00%

Download Data